Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

6 results about "Mesenchymal stem cell" patented technology

Mesenchymal stem cells are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue).

Serum-free culture system for efficiently culturing human umbilical cord mesenchymal stem cells in vitro

InactiveCN104164405AGood repeatabilityImprove passaging stabilitySkeletal/connective tissue cellsAntioxidantCytokine
The invention relates to a serum-free culture system for efficiently culturing human umbilical cord mesenchymal stem cells in vitro. The serum-free culture system comprises the following components: a basal culture medium a-MEM, cell factors, hormones and proteins, unsaturated fatty acids, antioxidants, energy substances, an amino acid additive, vitamins and metal additives. The serum-free culture system comprises simple and clear components, is free from harms of pathogens, does not have difference between batches, has good repeatability, can obtain plenty of high-quality human umbilical cord mesenchymal stem cells in a short time and has high passage stability, so that the serum-free culture system can be applied to scientific researches and can provide high-purity vibrant cells for cell therapy as a mating system in cell therapy.
Owner:CYAGEN BIOSCI INC

Preparation method of human adipose mesenchymal stem cell exosome for treating myocardial infarction

PendingCN111944749AExosome effect is stableDamage reliefCell dissociation methodsSkeletal/connective tissue cellsCardiac functioningCytokine
The invention provides a preparation method of human adipose mesenchymal stem cell exosome for treating myocardial infarction, and relates to the technical field of biology. The preparation method ofthe human mesenchymal stem cell exosome for treating myocardial infarction provided by the invention comprises the following steps: culturing human adipose mesenchymal stem cells, and collecting a cell culture solution; and carrying out differential centrifugation on the cell culture solution, collecting the supernatant, carrying out ultracentrifugation on the supernatant to obtain target microspheres, and then filtering, purifying and sterilizing the target microspheres to obtain the human adipose mesenchymal stem cell exosome for treating myocardial infarction. According to the present invention, the advantage is that the human adipose mesenchymal stem cell exosome is prepared by culturing human adipose mesenchymal stem cells, and the human adipose mesenchymal stem cell exosome containsvarious RNAs and cytokines, so that infarcted myocardial cells are effectively repaired, the cardiac function is enhanced, compensatory myocardial load is reduced, and heart failure is relieved; and atreatment medicine or a treatment strategy is provided for myocardial infarction.
Owner:FUJIAN MEDICAL UNIV UNION HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products